-
Over 1 million migrants apply for Spain's mass regularisation: PM
-
S. Africa deploys police as anti-migrant protests loom
-
Thousands from Philippine sect protest pro-Duterte senator's graft case
-
Monaco parcel bomb blast wounds Ukrainian oligarch
-
South Africa repatriations top 25,000 ahead of anti-immigrant ultimatum
-
Sweden face France's attacking firepower at the World Cup
-
Taiwan raids tech firms in China AI chip smuggling probe
-
Online same-sex romance series embrace AI 'freedom'
-
Morocco 'unstoppable' says coach after Netherlands thriller
-
New Oxford academic centre symbolises UK's big-donor era
-
Russia's small businesses pay the price of spiralling Ukraine war
-
Trump says Iran meeting set in Qatar, despite uncertainty
-
Paraguay shock Germany as Brazil, Morocco advance at World Cup
-
Morocco down Netherlands to reach World Cup last 16
-
NASA robot mission aiming to rescue space telescope
-
Asian stocks unable to track Wall St higher, yen holds at 40-year low
-
Mouse-that-roared Paraguay savors World Cup win over Germany
-
'We came from nothing': DR Congo dreams of England World Cup upset
-
Taiwan's ageing seaweed harvesters hope younger women wade in
-
Peruvian political heir Fujimori wins presidency
-
Key Venezuela port opens with US aid, as burials begin
-
What to expect as EU small parcel levy kicks in
-
Ambitious Japan search for answers after World Cup exit
-
Nagelsmann says won't 'run away' after Germany World Cup exit
-
How NATO will try to keep Trump happy at Ankara summit
-
Paraguay coach salutes 'extraordinary' World Cup win over Germany
-
Ultra-wealthy Chinese exile in New York sentenced to 30 years for fraud
-
Japan fans stunned as Brazil end their World Cup dream
-
Years on, families bury 68 Indigenous victims of Guatemala civil war
-
'Powerhouse' Haaland leads by example at World Cup: Norway coach Solbakken
-
'Deliberate' Monaco explosion wounds Ukrainian oligarch
-
Sadness and joy as breakaway Catholic group nears schism
-
Paraguay shock Germany, Brazil advance at World Cup
-
HUNTING/HER Headhunter Talk with EnBW Board Member & CHRO Colette Rückert-Hennen
-
SP Industries Inc. Leverages Bioz to Unify Scientific Validation Across Its Portfolio of Leading Brands
-
Apex Mobilizes Drill Rig and Commences 2026 Exploration Program at the Cap Critical Minerals Project
-
Creality Printers Review Site Help Buyers Compare Creality Printers
-
Tenstorrent Sets New Performance Records, Launches TT- Ascalon S, and Expands Across Japan
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 30
-
Guardian Metal Resources PLC Announces Pilot Mountain Pre-Feasibility Study Results
-
Germany dumped out by Paraguay in seismic World Cup shock
-
'I recognized her ring': identifying Venezuela's dead in a makeshift morgue
-
More than 1,000 drones detected since start of World Cup: FBI
-
Tuchel defensive headache as England ready for DR Congo clash
-
Extreme heat warning issued for World Cup host Kansas City
-
US reopens Venezuela port as quake deaths top 1,700
-
Bloodied but unbowed: Sinner, Djokovic survive Wimbledon scares
-
Coach says Japan getting closer to World Cup glory despite defeat
-
Djokovic battles past Wu in 'challenging' Wimbledon first round
-
NBA Grizzlies deal Morant to Portland: report
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.A.Mendoza--AT